Skip to main content
logo
Novavax, Inc. (LON:0A3S)
London flag London · Delayed Price · Currency is GBP · Price in USD
8.01
-0.06 (-0.74%)
At close: Sep 10, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Innovative Vaccines
190.21M
Log In
Log In
Log In
Log In
Upgrade
Innovative Vaccines Growth
-64.20%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Europe
93.27M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-65.24%
Log In
Log In
Log In
Log In
Upgrade
North America
65.02M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
117.04%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
31.92M
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-86.30%
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade